• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Echo Res Pract . Correlation between worsening pneumonitis and right ventricular systolic function in critically ill patients with COVID-19

tetano

Editor, Senior Moderator
Echo Res Pract


. 2024 Aug 1;11(1):19.
doi: 10.1186/s44156-024-00054-z. Correlation between worsening pneumonitis and right ventricular systolic function in critically ill patients with COVID-19

Hazem Lashin[SUP] 1 2 [/SUP], Jonathan Aron[SUP] 3 [/SUP], Shaun Lee[SUP] 3 [/SUP], Nick Fletcher[SUP] 3 4 [/SUP]



Affiliations
Abstract

Background: The pneumonitis associated with coronavirus disease 2019 (COVID-19) infection impacts the right ventricle (RV). However, the association between the disease severity and right ventricular systolic function needs elucidation.
Method: We conducted a retrospective study of 108 patients admitted to critical care with COVID-19 pneumonitis to examine the association between tricuspid annular plane systolic excursion (TAPSE) by transthoracic echocardiography as a surrogate for RV systolic function with PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio as a marker of disease severity and other respiratory parameters.
Results: The median age was 59 years [51, 66], 33 (31%) were female, and 63 (58%) were mechanically ventilated. Echocardiography was performed at a median of 3 days [2, 12] following admission to critical care. The PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] and TAPSE medians were 20.5 [14.4, 32.0] and 21 mm [18, 24]. There was a statistically significant, albeit weak, association between the increase in TAPSE and the worsening of the PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio (r[SUP]2[/SUP] = 0.041, p = 0.04). This association was more pronounced in the mechanically ventilated (r[SUP]2[/SUP] = 0.09, p = 0.02). TAPSE did not correlate significantly with FiO[SUB]2[/SUB], PaO[SUB]2[/SUB], PaCO[SUB]2[/SUB], pH, respiratory rate, or mechanical ventilation. Patients with a TAPSE ≥ 17 mm had a considerably worse PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio than a TAPSE < 17 mm (18.6 vs. 32.1, p = 0.005). The PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio predicted TAPSE (OR = 0.94, p = 0.004) with good area under the curve (0.72, p = 0.006). Moreover, a PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio < 26.7 (moderate pneumonitis) predicted TAPSE > 17 mm with reasonable sensitivity (67%) and specificity (68%).
Conclusion: In patients admitted to critical care with COVID-19 pneumonitis, TAPSE increased as the disease severity worsened early in the course of the disease, especially in the mechanically ventilated. A TAPSE within the normal range is not necessarily reassuring in early COVID-19 pneumonitis.

Keywords: ARDS; COVID-19; Echocardiography; Right ventricle.

 
Back
Top Bottom